Theravance Biopharma Inc TBPH
17.03 USD 0.00 (+0.00%)
At closeSep 23, 2026, 4:00 PM EDT
17.63 +0.60 +3.52%
After hours · Sep 23, 4:00 PM ET
17.02 Day range 17.07
7.44 52-week range 11.71
- YTD
- -8.98%
- 1 year
- +58.71%
TBPH revenue history
Revenue is income from the company’s ordinary business activities.
107,464,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 107,464,000 | 43,083,000 | 66.92% |
| FY 2024 | 2024-12-31 | 64,381,000 | 6,957,000 | 12.12% |
| FY 2023 | 2023-12-31 | 57,424,000 | 6,078,000 | 11.84% |
| FY 2022 | 2022-12-31 | 51,346,000 | -3,965,000 | -7.17% |
| FY 2021 | 2021-12-31 | 55,311,000 | -16,546,000 | -23.03% |
| FY 2020 | 2020-12-31 | 71,857,000 | -1,557,000 | -2.12% |
| FY 2019 | 2019-12-31 | 73,414,000 | 13,044,000 | 21.61% |
| FY 2018 | 2018-12-31 | 60,370,000 | 44,984,000 | 292.37% |
| FY 2017 | 2017-12-31 | 15,386,000 | -33,262,000 | -68.37% |
| FY 2016 | 2016-12-31 | 48,648,000 | 6,522,000 | 15.48% |
| FY 2015 | 2015-12-31 | 42,126,000 | 30,438,000 | 260.42% |
| FY 2014 | 2014-12-31 | 11,688,000 | 11,462,000 | 5071.68% |
| FY 2013 | 2013-12-31 | 226,000 | -129,919,000 | -99.83% |
| FY 2012 | 2012-12-31 | 130,145,000 | 115,291,000 | 776.16% |
| FY 2011 | 2011-12-31 | 14,854,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-08T14:23:33.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.